A1cCalculator

A1C 5.6% — what it means

An HbA1c of 5.6% corresponds to an estimated average glucose of 114 mg/dL (6.3 mmol/L) and an IFCC value of 38 mmol/mol. Normal

A1C to average glucose

Result summary for an A1C of 5.6%

MeasureValue
NGSP / DCCT A1C5.6%
IFCC A1C38 mmol/mol
Estimated average glucose (eAG)114 mg/dL
eAG in mmol/L6.3 mmol/L
Category (ADA)Normal
Points from 5.7% prediabetes cut point-0.1
Points from 6.5% diabetes cut point-0.9
Points from 7.0% common treatment goal-1.4
Typical average glucose spread (ADAG 95% CI, interpolated)90–139 mg/dL

A normal result

An A1C of 5.6% is in the normal range. ADA defines prediabetes as 5.7% to 6.4% and diabetes as 6.5% or higher, so this result is 0.1 percentage points below the prediabetes threshold. The estimated average glucose for 5.6% is about 114 mg/dL (6.3 mmol/L).

Risk of type 2 diabetes still rises gradually across the normal range, so a value in the mid-5s does not rule out future change, especially with overweight, a family history of diabetes, a history of gestational diabetes or high blood pressure. ADA recommends screening adults from age 35, and earlier for people with risk factors, with repeat testing at least every 3 years when results are normal.

Practical next steps

A1C values near 5.6%

Each 0.1 point of A1C equals about 2.9 mg/dL (0.16 mmol/L) of average glucose and about 1.1 mmol/mol on the IFCC scale.

A1CeAG mg/dLeAG mmol/LIFCC mmol/molCategory
4.6%854.727Normal
4.7%884.928Normal
4.8%915.029Normal
4.9%945.230Normal
5.0%975.431Normal
5.1%1005.532Normal
5.2%1035.733Normal
5.3%1055.834Normal
5.4%1086.035Normal
5.5%1116.237Normal
5.6%1146.338Normal
5.7%1176.539Prediabetes
5.8%1206.640Prediabetes
5.9%1236.841Prediabetes
6.0%1257.042Prediabetes
6.1%1287.143Prediabetes
6.2%1317.344Prediabetes
6.3%1347.445Prediabetes
6.4%1377.646Prediabetes
6.5%1407.748Diabetes range
6.6%1437.949Diabetes range

How 5.6% compares with ADA goals

Goals differ by age, health and pregnancy. The ADA sets them individually; the figures below are the default goals in the Standards of Care.

GroupGoalThis result
Most non-pregnant adults with diabetes<7.0%Meets goal (1.4 below)
Healthy older adults (few chronic illnesses, intact cognition and function)<7.5%Meets goal (1.9 below)
Older adults with complex or intermediate health<8.0%Meets goal (2.4 below)
Children and adolescents with diabetes<7.0%Meets goal (1.4 below)
Pregnancy with pre-existing diabetes<6.0%Meets goal (0.4 below)

How much higher would matter

ThresholdIncrease neededeAG at threshold
5.7%+0.1 points117 mg/dL
6.5%+0.9 points140 mg/dL
7.0%+1.4 points154 mg/dL

Which weeks shaped this A1C

Hemoglobin glycation follows red blood cell turnover, so recent weeks count more. Kinetic modeling (Tahara and Shima, 1995) found that the most recent 30 days contribute about half of the A1C value. That is why a change in treatment shows up partially after one month and mostly after three.

Period before the testShare of A1CShare of the 114 mg/dL average
Last 30 daysabout 50%57 mg/dL weight
30 to 60 days beforeabout 25%29 mg/dL weight
60 to 120 days beforeabout 25%29 mg/dL weight

When an A1C of 5.6% may not match your meter

Frequently asked questions

Is an A1C of 5.6% good?

An A1C of 5.6% is in the normal range (below 5.7%).

What average blood sugar is an A1C of 5.6%?

Using the ADAG formula eAG = 28.7 × A1C − 46.7, an A1C of 5.6% equals about 114 mg/dL, or 6.3 mmol/L.

What is 5.6% A1C in mmol/mol?

With the IFCC master equation, (5.6 − 2.152) × 10.929 gives 38 mmol/mol.

Is 5.6% A1C diabetes?

No. Diabetes is diagnosed at 6.5% or higher; 5.6% is 0.9 points below that.

How long does it take to change an A1C of 5.6%?

Because the last 30 days carry about half the weight, a sustained change in average glucose begins to show after about 4 weeks, and most of it is reflected after 8 to 12 weeks. ADA suggests retesting about every 3 months after a treatment change.

Related pages

Sources

  1. Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values (ADAG Study). Diabetes Care. 2008;31(8):1473-1478.
  2. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 2: Diagnosis and Classification of Diabetes. Diabetes Care. 2026;49(Suppl 1).
  3. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 6: Glycemic Goals and Hypoglycemia. Diabetes Care. 2026;49(Suppl 1).
  4. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 13: Older Adults. Diabetes Care. 2026;49(Suppl 1).
  5. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 14: Children and Adolescents. Diabetes Care. 2026;49(Suppl 1).
  6. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 15: Management of Diabetes in Pregnancy. Diabetes Care. 2026;49(Suppl 1).
  7. Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes. Clin Chem. 2004;50(1):166-174. NGSP/IFCC master equation.
  8. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995;18(4):440-447.
  9. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
  10. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ. 2000;321(7258):405-412.
  11. National Glycohemoglobin Standardization Program (NGSP). Harmonizing hemoglobin A1c testing; factors that interfere with HbA1c test results.

This page is for education and does not replace advice from your doctor. Diagnosis of diabetes requires laboratory testing and, in most cases, a repeat test.